Literature DB >> 17892925

In vitro genotoxicity tests for polyhydroxybutyrate--a synthetic biomaterial.

Abdulaziz Qaid Ali1, Thirumulu Ponnuraj Kannan, Azlina Ahmad, Ab Rani Samsudin.   

Abstract

The aims of this study are to determine the mutagenicity of a locally produced polyhydroxybutyrate (PHB) using Salmonella mutagenicity test and to find out if PHB altered the expression of p53 and c-myc proto-oncogenes and bcl-xl and bcl-xs anti-apoptotic genes in the human fibroblast cell line, MRC-5. Different concentrations of PHB were incubated with special genotypic variants of Salmonella strains (TA1535, TA1537, TA1538, TA98 and TA100) carrying mutations in several genes both with and without metabolic activation (S9) and the test was assessed based on the number of revertant colonies. The average number of revertant colonies per plate treated with PHB was less than double as compared to that of negative control. For the gene expression analyses, fibroblast cell lines were treated with PHB at different concentrations and incubated for 1, 12, 24 and 48 h separately. The total RNA was isolated and analysed for the expression of p53, c-myc, bcl-xl and bcl-xs genes. The PHB did not show over or under expression of the genes studied. The above tests indicate that the locally produced PHB is non-genotoxic and does not alter the expression of the proto-oncogenes and anti-apoptotic genes considered in this study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17892925     DOI: 10.1016/j.tiv.2007.08.001

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  2 in total

1.  PLLA-PHB fiber membranes obtained by solvent-free electrospinning for short-time drug delivery.

Authors:  K Cao; Y Liu; A A Olkhov; V Siracusa; A L Iordanskii
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

Review 2.  Craniofacial Bone Tissue Engineering: Current Approaches and Potential Therapy.

Authors:  Arbi Aghali
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.